Catalyst Wire Dossier Catalyst Wire Dossier

Neumifil

neumifil · Pneumagen Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Neumifil, covering 2024-01-11 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model [Phase 2]

See pricing